Epigenetics, predictive signals of satiety and obesity

Published Date: 02 Mar 2023

Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.

Read Full News

Latest News

Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success

Viridian Therapeutics' experimental treatment for thyroid eye ⁠disease lagged rivals in efficacy in a late-stage...

BMI Misclassifies Many Adults With Obesity

Researchers using the gold-standard DEXA to measure body fat percentage showed that BMI misclassified a notable proportion of adults, placing many in incorrect weight categories.

Beyond Diabetes Control: Tirzepatide Boosts Quality of Life

Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

Novo Nordisk Cuts Ozempic, Wegovy Prices in India Again to Fight Cheaper Generics

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ⁠48% in India, to fend off competition from...

Tirzepatide Boosts Metabolic Health in Partial Lipodystrophy

Tirzepatide significantly improves metabolic health and reduces insulin dependence in patients with partial lipodystrophy.

EMA Clears New First-Line Options for Advanced Cancers

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Latest News

Viridian Therapeutics' experimental treatment for thyroid eye ⁠disease lagged rivals in efficacy in a late-stage...

Researchers using the gold-standard DEXA to measure body fat percentage showed that BMI misclassified a notable proportion of adults, placing many in incorrect weight categories.

Switching to tirzepatide yields greater quality-of-life benefits than increasing the dulaglutide dose in patients with type 2 diabetes.

Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and ⁠48% in India, to fend off competition from...

Tirzepatide significantly improves metabolic health and reduces insulin dependence in patients with partial lipodystrophy.

European regulators have backed RET inhibitor and PD-1 regimens, expanding first line options in advanced lung, thyroid, and esophageal cancers.

News All Time

Dad’s Nicotine Use May Shape Kids’ Metabolic Health

Paternal nicotine use alters metabolism in offspring, and those changes are sex-specific, a study in mice shows.

Dementia Risk May Triple With Type 1 Diabetes

The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease, new research shows.

Elinzanetant Reduces Vasomotor Symptoms in Breast Cancer

Elinzanetant reduces the severity and frequency of hot flushes and night sweats among women with breast cancer regardless of type of endocrine treatment used.

Does Eating the Same Foods Work Best for Weight Loss?

Repeating the same meals and keeping calorie intake steady produces more weight loss than eating a more varied diet among individuals living with overweight or obesity.

Germany Renews Push for Sugar Tax & Energy Drinks Ban for Kids

A German push to tax sugary drinks and ban energy drinks for under-16s will be voted on by the country's assembly of regional states on Friday.

Quarter of Weight Loss Persists After Stopping GLP-1 Drugs

Individuals stopping GLP-1 receptor agonists regain most lost weight within 1 year, but about one quarter of the weight reduction may persist long term.

Which Factors Predict Progression From Prediabetes to T2D?

A real-world study suggests that adults with prediabetes are more likely to develop type 2 diabetes if they are aged 35-64 years vs 18-34 years or have certain comorbidities.

Preventing Deficiencies After Bariatric Surgery

After bariatric surgery, deficits in B vitamins, vitamin D, iron, and zinc are common — early detection, lifelong supplementation, and tailored monitoring are essential.

Kodiak Sciences Eye Drug Succeeds in Late-stage Study

Kodiak Sciences' experimental drug met the main goal in a late-stage trial.

How Muscle Remembers Weakness — and the Impact on Frailty Risk

New research reveals that muscle retains memory of disuse, potentially explaining why returning to activity after an injury or illness is so much harder for older patients.

Use of Advanced Therapies for RA Doesn’t Stop Bone Loss

Though disease activity is controlled with biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with RA, bone mineral density still decreases.

Blame for Obesity Common Among Patients, Clinicians Globally

Obesity, a chronic disease, is still treated as a personal failing.

Colon Cleanses Pose Risks With No Proven Benefit

Colon cleansing claims are unsupported by evidence, while adverse effects, including hyponatremia, hypokalemia, and nephropathy, are well documented.

US Senators Reach Deal on Capping Insulin Costs At $35 Per Month, Semafor Reports

A bipartisan group of ⁠U.S. senators has reached a ⁠deal on capping the ⁠price of ‌a month's supply of insulin at $35, Semafor reported on Wednesday, citing ‌an interview...

Menopause: When to Treat and When to Wait

Early menopause demands tailored care: Premature estrogen loss increases bone loss and cardiovascular risk, so management should differ from typical cases.

Can AI Improve Glaucoma Screening in Primary Care Settings?

AI-based screening for glaucoma can be implemented in primary care within existing screening programmes, enhancing efficiency and detection.

Recommended News For You

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Radiotherapy after mastectomy can be avoided, study finds

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

Biocomputer From Human Neurons Plays Doom, Raises Ethics

Recommended Articles For You

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis  

Unlocking the Benefits of Eltrombopag: A Comprehensive Guide 

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer 

The Pros and Cons of Steroid Therapy for ITP 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer

2.

AI innovation unlocks non-surgical way to detect brain cancer spread

3.

Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.

4.

For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

5.

Kate Middleton Reaches Cancer Treatment Milestone

1.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

2.

A Closer Look at Breast Cancer: Examining the Ultrasound Images

3.

ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection

4.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

5.

The Science Behind Thrombolytic Drugs and Their Benefits 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

2.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

3.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot